Furthermore, in cases of renal cell carcinoma [11] and gastric carcinoma [12], patients with tumor PD-L1 are at a significantly increased risk of rapid disease progression and overall mortality, suggesting that PD-L1 is associated with poor prognosis in patients with tumors. Here, CD274 is linked to gastric carcinoma.